Sachs Jessica 4
4 · Cogent Biosciences, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
Sachs Jessica
Chief Medical Officer
Transactions
- Award
Common Stock
2021-12-31$6.82/sh+674$4,595→ 674 total
Footnotes (1)
- [F1]The shares were acquired under the Cogent Biosciences, Inc. 2018 Employee Stock Purchase Plan. The transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).